3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Alcohol Drinking
5
Prostatic Neoplasms
2
Head and Neck Neoplasms
2
Substance-Related Disorders
1
Social Isolation
1
Smoking Cessation
1
Risk-Taking
1
Pancreatic Cyst
1
Pain
1
Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Flushing
1
Fanconi Anemia
1
Esophageal Neoplasms
1
Driving Under the Influence
1
Depression
1
Colorectal Neoplasms
1
Carney Complex
1
Cardiovascular Diseases
1
Binge-Eating Disorder
1
Binge Drinking
1
Alzheimer Disease
1
Agnosia
1
Interventions
Cyclophosphamide
8
Rituximab
5
fludarabine
4
Vincristine
4
Prednisone
4
Doxorubicin
4
fludarabine phosphate
3
Tacrolimus
3
Mycophenolic Acid
3
Etoposide
3
Busulfan
3
venetoclax
2
entrectinib
2
atezolizumab
2
alectinib
2
acalabrutinib
2
Whole-Body Irradiation
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mesna
2
Melphalan
2
Bortezomib
2
trametinib
1
pertuzumab
1
pembrolizumab
1
obinutuzumab
1
liposomal doxorubicin
1
isatuximab
1
ibrutinib
1
etoposide phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoproliferative Disorders
×
Ethanol
×
1 year
×
Clear all
No trials found.